Discover 1,249 paid clinical trials in Murfreesboro, Tennessee. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,249
Comparing Healthcare Visit Recording and Open Notes to Improve Chronic iLlness Care Experience in Older Adults
for
Diabetes Mellitus, Hypertension
Location: Nashville TN, Manchester NH
Sponsor: Dartmouth-Hitchcock Medical Center
Sex: All
Age: 18+
Code: NCT05955339
Recruiting
LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
for
Superficial Bladder Cancer,
Location: Nashville TN, Birmingham AL, Atlanta GA, Cincinnati OH,
Sponsor: enGene, Inc.
Sex: All
Age: 18+
Code: NCT04752722
Phase1, Phase2, Recruiting
Reciprocal Imitation Training and Musical Rhythm Sensitivity in Autistic Toddlers
for
Autism, Autism Spectrum Disorder
Location: Nashville TN
Sponsor: Vanderbilt University Medical Center
Sex: All
Age: 1 - 3
Code: NCT05880225
Recruiting
Effect of Raised Head of the Bed on Lying Blood Pressure in Autonomic Failure
for
Supine Hypertension, Autonomic Failure
Location: Nashville TN
Sponsor: Vanderbilt University Medical Center
Sex: All
Age: 18 - 70+
Code: NCT04502225
Recruiting
Disposable Perfusion Phantom for Accurate DCE (Dynamic Contrast Enhanced)-MRI Measurement of Pancreatic Cancer Therapy Response
for
Pancreatic Cancer
Location: Nashville TN, Columbus OH
Sponsor: Ohio State University
Sex: All
Age: 19+
Code: NCT04588025
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Risk and Resilience in Pulmonary Arterial Hypertension and Genetically Susceptible Individuals
for
Idiopathic Pulmonary Arterial Hypertension,
Location: Nashville TN
Sponsor: Vanderbilt University Medical Center
Sex: All
Age: 15 - 70+
Code: NCT05584722
Recruiting
Artificial Tears to Prevent Nasolacrimal Duct Obstruction in Patients Treated With Radioactive Iodine for Thyroid Cancer
for
Nasolacrimal Duct Obstruction, Thyroid Cancer
Location: Nashville TN
Sponsor: Vanderbilt University Medical Center
Sex: All
Age: 18+
Code: NCT05999630
Phase3, Recruiting
Canakinumab for the Prevention of Progression to Cancer in Patients With Clonal Cytopenias of Unknown Significance, IMPACT Study
for
Clonal Cytopenia of Undetermined Significance
Location: Nashville TN, Columbus OH, Dallas TX, New York NY,
Sponsor: Uma Borate
Sex: All
Age: 18+
Code: NCT05641831
Phase2, Recruiting
Assessment of the Ocular Microbiome in Health and Disease
Use of CereGate Therapy for Freezing of Gait in PD
for
Parkinson Disease, Freezing of Gait, Deep Brain Stimulation
Location: Nashville TN, Winston-Salem NC, Chicago IL, Miami FL,
Sponsor: CereGate Inc.
Sex: All
Age: 21 - 70+
Code: NCT05292794
Recruiting
Prospective Clinical Assessment Study in Children With Hypochondroplasia
for
Hypochondroplasia
Location: Nashville TN, Cincinnati OH, Columbia MO, Madison WI,
Sponsor: QED Therapeutics, a BridgeBio company
Sex: All
Age: 2 - 16
Code: NCT06410976
Recruiting
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
for
Colorectal Neoplasms
Location: Nashville TN, Chattanooga TN, Atlanta GA, Athens GA,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT06750094
Phase3, Recruiting
Home-Based Cardiac Rehabilitation for Patients With Heart Failure
for
Heart Failure With Preserved Ejection Fraction,
Location: Nashville TN
Sponsor: Vanderbilt University Medical Center
Sex: All
Age: 18+
Code: NCT06479876
Recruiting
VZV in the Enteric Nervous System: Pathogenesis and Consequences
for
Achalasia
Location: Nashville TN
Sponsor: Vanderbilt University Medical Center
Sex: All
Age: 18 - 70+
Code: NCT05550194
Recruiting
Low-Dose Short-Term Ketorolac to Reduce Chronic Opioid Use in Orthopaedic Polytrauma Patients
for
Orthopaedic Trauma, Chronic Opioid Use
Location: Nashville TN, Boston MA
Sponsor: Massachusetts General Hospital
Sex: All
Age: 18 - 70
Code: NCT06201676
Recruiting
Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL